Regulators news from FiercePharma
News
Silver lining to Big Pharma's cloud?
Some people see the Big Pharma glass as half-full instead of the alternative. In an investor's-eye look at the industry, Kiplinger ticks off the usual criticisms: patent expirations, tough generics Read more...
FDA: Drugmakers responsible for safety
Congress may be all fired up about funding more foreign inspections by the FDA, but the agency itself? Not so much. In Read more...
Brazil mulls patent-busting on Tenofovir
The Brazilian government recently deemed the anti-HIV med Tenofovir a "public interest." That's code for, "We're thinking about issuing a compulsory license for this drug." Under Read more...
Impurities found in Sanofi heparin product
While heparin maker Baxter mulls whether to re-enter the market for that blood thinner, Sanofi-Aventis is announcing that small amounts of an impurity have been found in batches of its heparin Read more...
New companies flooding CMO market
More evidence that biologic drugs are where it's at: Experts are predicting tough times ahead for contract manufacturers that focus too closely on Big Pharma's bread-and-butter small-molecule Read more...
Teva to expand in Spain with Bentley buy
Teva Pharmaceutical is on an expansion quest. Today it's agreed to buy Bentley Read more...
Could full data disclosure avert scandal?
New calls for old drug data in the U.K. have experts second-guessing big drug-safety scandals. If scientists and regulators had had access to every bit of data on Vioxx from the get-go, for instance, Read more...
Companies saw Vytorin threat in 2005
Merck and Schering-Plough officials overseeing the Enhance study saw a threat to Vytorin back in late 2005, the Wall Street Journal reports. Study participants were healthier than officials thought Read more...
Heparin scare widens to Germany
The heparin problem is no longer a discrete, well-defined mess. Regulators in Germany yesterday announced that Chinese-sourced heparin sold in that country has been linked to two outbreaks of Read more...
Get more Regulators coverage at:
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight